Sep 25, 2019 / 01:00PM GMT
Operator
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to today's FDA Approval of JYNNEOS Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Wednesday, the 25th of September 2019.
I would like now to hand the conference over to your speaker today, Henrik Juuel. Please go ahead, sir.
Henrik Juuel - Bavarian Nordic A/S-CFO&Executive VP
Good morning, and good afternoon to all listeners out there. This is Henrik Juuel, the CFO, and I have with me here our CEO, Paul Chaplin. And we have the pleasure today to have this audiocast to talk about the approval of our smallpox and monkeypox vaccine, JYNNEOS.
But before I hand over the word to Paul, I would like to just take you through the forward-looking statements slide on Slide #2, which says this presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to
Bavarian Nordic A/S - Special Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers